Hisakazu Shindou

Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.

Takashi Tsuji, Shigekazu Hidaka, Terumitsu Sawai et al. · PubMed · 2003 · 80 citations

Medicine, Genetics, Oncology +14

Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy

Atsushi Nanashima, Yorihisa Sumida, Takafumi Abo et al. · Journal of Gastroenterology · 2006 · 44 citations

Medicine, Oncology, Surgery +14

Parameters Associated with Changes in Liver Volume in Patients Undergoing Portal Vein Embolization

Atsushi Nanashima, Yorihisa Sumida, Shinichi Shibasaki et al. · Journal of Surgical Research · 2006 · 29 citations

Medicine, Surgery, Hemodynamic Management +13

Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection

Atsushi Nanashima, Hiroshi Yano, Hiroyuki Yamaguchi et al. · Journal of Gastroenterology · 2004 · 25 citations

Medicine, Oncology, Pathology +17